Regulatory press release2024-08-01 08:45The subscription period in Cyxone's rights issue starts today
Regulatory press release2024-07-23 08:30Cyxone: Styrelsen beslutar om företrädesemission om högst cirka 23 MSEK för att finansiera fortsatt utveckling av rabeximod och T20K
Regulatory press release2024-07-23 08:30Cyxone: The board decides on a rights issue of a maximum of approximately SEK 23 million to finance continued development of rabeximod and T20K